Sign In
Buy CCXI
$15.55
-0.680 (-4.19%)
At Close: Jul 10, 2026
Churchill Capital Stock Is Surging Wednesday: What Investors Need to Know
09:18am, Wednesday, 01'st Jul 2026
Churchill Capital Corp XI (NASDAQ:CCXI) shares are up during Wednesday's premarket session, trading higher by almost 11% as traders continue to weigh the latest SEC filing details tied to its definiti
Humanoid robot startup Agility Robotics is going public at a $2.5 billion valuation via a SPAC
05:00pm, Wednesday, 24'th Jun 2026
Agility Robotics plans to go public via a SPAC at a $2.5 billion valuation. Agility has deployed Digit robots at Amazon, Toyota, and the logistics firm GXO.
Agility Robotics heads to Wall Street in a $2.5B bet on staffing warehouses with humanoids
04:40pm, Wednesday, 24'th Jun 2026
A maker of humanlike robots that carry totes around warehouses is going public on Wall Street in a test of whether there's a market for putting AI-powered humanoid machines to work.
Agility Robotics to Go Public Through $2.5 Billion Merger with Churchill Capital Corp XI
06:00am, Wednesday, 24'th Jun 2026
SALEM, Ore. & NEW YORK--(BUSINESS WIRE)--Agility Robotics, Inc. (“Agility” or the “Company”), a leading humanoid robotics and physical AI company, and Churchill Capital Corp XI (NASDAQ: CCXI)
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026
04:28pm, Thursday, 05'th Feb 2026
New York, NY, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Churchill Capital Corp XI (Nasdaq: CCXIU) (the “Company”) announced today that, commencing February 9, 2026, holders of the units sold in the Compan
AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX
09:05am, Thursday, 20'th Oct 2022
TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif. , Oct. 20, 2022 /PRNewswire/ -- Amgen
-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS ® (avacopan) for patients with ANCA-associated vasculitis; additional poster wil
Is ChemoCentryx (CCXI) Stock Outpacing Its Medical Peers This Year?
11:17am, Thursday, 06'th Oct 2022
Here is how ChemoCentryx (CCXI) and Eiger BioPharmaceuticals (EIGR) have performed compared to their sector so far this year.
-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN CARLOS,
NEW YORK--(BUSINESS WIRE)--Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, is investigating whether certain directors and officer
Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth
05:09pm, Thursday, 08'th Sep 2022
Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.
Why Is ChemoCentryx (CCXI) Up 1.4% Since Last Earnings Report?
12:48pm, Wednesday, 07'th Sep 2022
ChemoCentryx (CCXI) reported earnings 30 days ago. What's next for the stock?
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ONEM, CCXI, AERI, SFT
11:26am, Thursday, 25'th Aug 2022
NEW YORK , Aug. 25, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches
ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences
08:30am, Wednesday, 24'th Aug 2022
SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in August and
Here's Why ChemoCentryx (CCXI) is a Great Momentum Stock to Buy
01:33pm, Tuesday, 16'th Aug 2022
Does ChemoCentryx (CCXI) have what it takes to be a top stock pick for momentum investors? Let's find out.
